New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
07:13 EDTTHORThoratec downgraded to Market Perform from Outperform at Northland Securities
Northland downgraded Thoratec following the CMS's announcement to initiate a National Coverage Decision analysis for VAD therapy. The firm believes there is now significant uncertainty regarding VADs and margins. Price target is $35.
News For THOR From The Last 14 Days
Check below for free stories on THOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for THOR

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use